
Synmedix: Treating infections with the next generation of antibiotics
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.

Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.

Original Article by Aileen Lalor, NUVO Magazine, September 23, 2022 A boom in technology for

The partnership between Koble and Maple will provide much-needed support for an underserved group – new and expecting parents.

$50,000 Awarded as 300 Members of the Innovation Community Celebrate HAMILTON, ON – September 29,

Take a listen to our latest podcast as Rachel Bartholomew, CEO and Founder of Hyivy Health shares her medical device commercialization journey.

Swati Matta, CEO & Founder of Koble, shares her startup journey and POV on the challenges of being a woman in the tech industry.

ORIGINAL PRESS RELEASE, Nicole Estrin, Innovative Health Diagnostics, August 16, 2022 Both laboratories join forces

Press Release: HyIvy Health Hyivy Health’s innovative pelvic health rehabilitation system looks to provide a

Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.

Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.

Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.

Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.

Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.

Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.

Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.

Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.

The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.